LEADER 06104cam a2200505Ii 4500
006 m o d
007 cr n
008 170626s2017 enka ob 001 0 eng d
a| 9780128092514 q| (electronic bk.)
a| 0128092513 q| (electronic bk.)
a| (OCoLC)ELSD991595773 z| (OCoLC)ELSD992399603 z| (OCoLC)ELSD992730912
a| N$T b| eng e| rda e| pn c| N$T d| N$T d| OPELS d| IDEBK d| EBLCP d| YDX d| MERER d| OCLCF d| OCLCQ d| UPM d| OCLCQ d| IDB d| NRC d| COO
a| TP248.2 b| .N36 2017eb
a| SCI x| 013060 2| bisacsh
a| TEC x| 009010 2| bisacsh
a| 660.6 2| 23
a| Nambisan, Padma, e| author.
a| An introduction to ethical, safety and intellectual property rights issues in biotechnology h| [electronic resource] / c| Padma Nambisan.
a| London : b| Elsevier : b| Academic Press, c| 
a| 1 online resource (xxi, 370 pages) : b| color illustrations.
a| text b| txt 2| rdacontent
a| computer b| c 2| rdamedia
a| online resource b| cr 2| rdacarrier
a| Includes bibliographical references and index.
a| Restricted for use by site license.
a| Vendor-supplied metadata.
a| Front Cover; An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology; Copyright Page; Dedication; Contents; Foreword; Preface; Acknowledgments; How to Use This Book; 1 Genes, Genomes, and Genomics; 1.1 Introduction; 1.2 The Development of Gene Concept; 1.3 Genes; 1.4 Genomes; 1.5 Genomics; 1.6 The Human Genome Project (HGP); 1.7 Applications of Genomics; 1.7.1 Phylogenetic Analysis; 1.7.2 Genetic Testing and Diagnostics; 1.7.3 Pharmacogenomics; 1.7.4 Forensics; 1.7.5 Recombinant DNA Technology; 1.7.6 Gene Therapy; 1.7.7 Genome Editing
a| 1.7.8 Synthetic Biology1.8 Ethical, Legal, and Social Implication; 1.9 Genetic Reductionism; 1.10 Summary; References; Further Reading; Reviews; Web resources; Human genome project; ELSI; Synthetic Biology; 2 Cloning; 2.1 Introduction; 2.2 Cloning Animals; 2.2.1 Dolly; 2.2.2 Progress in Cloning After Dolly; 2.2.3 Limitations of Nuclear Transfer; 2.2.4 Applications of Cloning; 188.8.131.52 Multiplication of elite strains of livestock for meat and milk; 184.108.40.206 Creation of transgenic livestock for production of pharmaceuticals ("Pharming")
a| 220.127.116.11 Creation of transgenic livestock for production of nutraceuticals18.104.22.168 Derivation of stem cells for cell-based therapies (therapeutic cloning); 22.214.171.124 Production of transgenic animals for xenotransplantation; 126.96.36.199 Models for understanding aging and cancer; 188.8.131.52 Conservation of rare breeds; 184.108.40.206 Cloning for companionship and entertainment; 2.2.5 Ethical Issues in Cloning Animals; 220.127.116.11 Pain and suffering experienced by the animals during the cloning process; 18.104.22.168 The effect of the cloned animals on other populations of animals
a| 22.214.171.124 Compromising the safety of food from livestock126.96.36.199 Effect on the environment; 188.8.131.52 Creation of unwanted animals; 184.108.40.206 Unnatural modification of animal species-"playing God"; 220.127.116.11 Potential for misleading bereaved pet owners regarding resurrection of their beloved pets; 2.2.6 Laws and Public Policy on Reproductive Cloning in Animals; 18.104.22.168 European Union; 22.214.171.124 United States of America; 126.96.36.199 Canada; 188.8.131.52 Argentina; 184.108.40.206 Brazil; 220.127.116.11 Australia; 18.104.22.168 Others; 2.3 Human Cloning; 2.3.1 Ethical Considerations; 22.214.171.124 "Playing God"
a| 126.96.36.199 Commodification of life188.8.131.52 Legal/Social status of a clone; 184.108.40.206 Safety/Health and quality of life of the clone; 220.127.116.11 Eugenics; 2.3.2 Laws and Public Policy on Reproductive Cloning in Humans; 18.104.22.168 The United Nations Declaration on Human Cloning; 22.214.171.124 UNESCO Universal Declaration on the Human Genome and Human Rights; 126.96.36.199 Council of Europe Convention on Human Rights and Biomedicine, 1998; 188.8.131.52 European Union Charter of Fundamental Rights, 2000; 184.108.40.206 Legislation at the National Level; 220.127.116.11.1 United Kingdom-Human Reproductive Cloning Act 2001
a| An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology provides a comprehensive look at the biggest technologies that have revolutionized biology since the early 20th century, also discussing their impact on society.The book focuses on issues related to bioethics, biosafety and intellectual property rights, and is written in an easy-to-understand manner for graduate students and early career researchers interested in the opportunities and challenges associated with advances in biotechnology.Important topics covered include the Human Genome Project, human cloning, rDNA technology, the 3Rs and animal welfare, bioterrorism, human rights and genetic discrimination, good laboratory practices, good manufacturing practices, the protection of biological material and much more.Full of relevant case studies, practical examples, weblinks and resources for further reading, this book offers an essential and holistic look at the ways in which biotechnology has affected our global society.Provides a comprehensive look at the ethical, legal and social implications of biotechnologyDiscusses the global efforts made to resolve issuesIncorporates numerous case studies to more clearly convey concepts and chart the development of guidelines and legislation regulating issues in biotechnologyTakes a straightforward approach to highlight and discuss both the benefits and risks associated with the latest biotechnologies.
a| Biotechnology x| Moral and ethical aspects.
a| Biotechnology x| Safety measures.
a| Intellectual property.
a| Electronic books.
c| Original z| 9780128092316 z| 0128092319 w| (OCoLC)974698931
u| http://hdl.library.upenn.edu/1017.12/2025035 z| Connect to full text
b| web h| - x| ELSD BioGen 2017